STEGLUJAN 15 mg/1

Steglujan 15 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 15 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar levels, often alongside diet and exercise. This combination medication targets multiple pathways to support glycemic control.

Common effects of Steglujan 15 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal discomfort. Individual responses can vary, and not everyone experiences these effects.

Handle Steglujan 15 mg/1 with care, especially if you have kidney issues or a history of pancreatitis. Always follow healthcare provider instructions and monitor blood sugar levels regularly.

Steglujan 15 mg/1 may interact with other medications, including insulin and certain antibiotics. Avoid alcohol and consult a healthcare provider before combining with other treatments.